The comparison of Rituximab and Cyclophosphamide for induction therapy in patients with granulomatosis with polyangiitis
International Journal of Rheumatic Diseases · 2024
DOI: 10.1111/1756-185x.15288 ↗Kurz gefasst
Leserbrief in der Zeitschrift International Journal of Rheumatic Diseases, 2024. Verfasst von Behrooz Izadi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Tehran University of Medical Science, Tehran, Iran. Hauptthemen laut MEDLINE: Rituximab, Cyclophosphamide, Granulomatosis with Polyangiitis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben.
Abstract (Originalsprache)
The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Tehran University of Medical Science, Tehran, Iran.
- Department of Internal Medicine, Imam Khomeini Hospital Complex (IKHC), Tehran University of Medical Science, Tehran, Iran.
ORCID-Profile: Behrooz Izadi, Seyed Behnam Jazayeri, Maryam Sadat Fakhri-Bafghi, Shima Loni
Zitieren
APA
Izadi, B., Jazayeri, S. B., Fakhri-Bafghi, M. S., & Loni, S. (2024). The comparison of Rituximab and Cyclophosphamide for induction therapy in patients with granulomatosis with polyangiitis. International Journal of Rheumatic Diseases. https://doi.org/10.1111/1756-185x.15288
Vancouver
Izadi B, Jazayeri SB, Fakhri-Bafghi MS, Loni S. The comparison of Rituximab and Cyclophosphamide for induction therapy in patients with granulomatosis with polyangiitis. International Journal of Rheumatic Diseases. 2024. doi:10.1111/1756-185x.15288
BibTeX
@article{Izadi2024,
author = {Izadi, Behrooz and Jazayeri, Seyed Behnam and Fakhri-Bafghi, Maryam Sadat and Loni, Shima},
title = {The comparison of Rituximab and Cyclophosphamide for induction therapy in patients with granulomatosis with polyangiitis},
journal = {International Journal of Rheumatic Diseases},
year = {2024},
doi = {10.1111/1756-185x.15288}
}
EUVIMED